Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae Immunoglobulin G and A Antibodies in a Healthy Finnish Population as Analyzed by Quantitative Enzyme Immunoassays
- 1 September 2000
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 7 (5) , 734-738
- https://doi.org/10.1128/cdli.7.5.734-738.2000
Abstract
Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G (IgG) and IgA antibody seroprevalence rates and antibody levels related to age and gender were studied. The samples ( n = 742) were collected during a nonepidemic period and analyzed by quantitative enzyme immunoassays (EIAs). Seroprevalence to C. pneumoniae was found to increase sharply in young children, and in the 15- to 19-year-old group it reached levels as high as 70 and 60% for IgG and IgA, respectively. After adolescence, seroprevalence showed a transient decrease and then continued to increase, although less dramatically than in early childhood. In the elderly the seroprevalence of IgG antibodies reached 75 and 100% in women and men, respectively. The corresponding rates of IgA antibodies were 73 and 100%. When a randomly selected subgroup of samples ( n = 66) was analyzed in parallel by a microimmunofluorescence test and an EIA for C. pneumoniae IgA antibodies, similar seroprevalence rates were obtained (36 versus 35%). Seroprevalence to M. pneumoniae was already found to increase very sharply in 2- to 4-year-old children, reaching 16% for IgG and 8% for IgA. Seroprevalence to M. pneumoniae also continued to increase in adolescence, but in contrast to that to C. pneumoniae , the increase leveled off at about 40 to 50% in adulthood. In subjects aged over 65 years, prevalence did not exceed 60% for IgG or 35% for IgA. The seroprevalence patterns as well as the medians and variations of levels of C. pneumoniae and M. pneumoniae IgG antibodies were similar to those of corresponding IgA antibodies. Compared to IgG antibodies, IgA antibodies do not seem to be of additional value in the diagnosis of infections caused by these pathogens when single serum specimens are studied.Keywords
This publication has 13 references indexed in Scilit:
- Comparison of Five Serologic Tests for Diagnosis of Acute Infections by Chlamydia pneumoniaeClinical and Diagnostic Laboratory Immunology, 2000
- Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study Commentary: Chlamydia pneumoniae infection and ischaemic heart diseaseBMJ, 1999
- Cardiovascular disease risk factors in young children in the STRIP baby project. Special Turku coronary Risk factor Intervention Project for children.1999
- Molecular evidence for the existence of additional members of the order ChlamydialesMicrobiology, 1999
- Pneumonia with Serological Evidence of Acute Infection with the Chlamydia-like Microorganism “Z”American Journal of Respiratory and Critical Care Medicine, 1997
- Detection of antibodies to Mycoplasma pneumoniae adhesin P1 in serum specimens from infected and non-infected subjects by immunoblottingDiagnostic Microbiology and Infectious Disease, 1996
- Chlamydia pneumoniae lgG Antibody Prevalence in South-Western and Eastern Finland in 1982 and 1987International Journal of Epidemiology, 1994
- Infections Caused by Mycoplasma pneumoniae and Possible Carrier State in Different Populations of PatientsClinical Infectious Diseases, 1993
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988